Sienna Biopharmaceuticals to Present at JMP Securities Life Science Conference
14 juin 2018 09h05 HE
|
Sienna Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief...